Eli Lilly FDA Grants Emergency Use Authorization for Eli Lilly, Sandia National Labs Coronavirus PCR Tests Both of the RT-PCR-based tests are designed to detect the SARS-CoV-2 nucleocapsid gene in a variety of swab samples and other specimens. Protypia, Lilly Show Mass Spec PD-L1 Measurements Vary Widely From IHC Results Premium The work suggests mass spec can more accurately assess levels of immunotherapy targets like PD-L1 than conventional clinical approaches. Colorectal Cancers Dial up Mutability in Response to Targeted Treatments A new study suggests that colorectal cancers increase their mutation rate to dodge treatment in a manner that mirrors microbial resistance mechanisms. Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium An IASLC survey showed that molecular testing is not performed in line with expert guidelines, which means only a minority of lung cancer patients are benefitting from precision oncology. Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor The firms plan to use Thermo Fisher's Oncomine Dx Target test to identify cancer patients with RET alterations who might benefit from Lilly's LOXO-292. Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Oct 26, 2018 Schizophrenia Drug Screening Improved Through Use of Patient-Derived Cells Dec 1, 2017 Genome Canada, Partners Commit C$24.6M for Genome Research Projects May 25, 2017 At Bio-IT World, CIOs Share Thoughts On Data Security, Software Obsolescence, Usability Premium Oct 17, 2016 White House Unveils New Initiatives to Advance Cancer Moonshot Oct 6, 2016 Pathologists' Group Takes Aim at Improving MDx Through Preanalytical Sample Quality Premium Oct 23, 2015 MED-C Launches First Registry in NSCLC With Funding Agreements from Pharma, Sequencing Companies Premium Jun 1, 2015 ASCO Launches Trial to Study Benefit of Off-Label Cancer Rx for Advanced Patients Using Genomic Info Premium Mar 3, 2015 Denovo Biopharma Taking Shot at Identifying Best Responders to Lilly's Failed Schizophrenia Drug Premium Sep 24, 2014 Denovo Taking on Failed Phase III Lilly Drug to Pursue for Genomic Responder Subset Premium Jun 5, 2014 Qiagen Buys PrimeraDx to Better Enable Multiplex CDx Development, with Lilly as First Partner Premium Jun 4, 2014 Two Large Negative Trials in Molecularly Defined Cancers Leave Clinicians Asking What's Next? Premium May 30, 2014 Qiagen, Lilly Ink CDx Development Pact Targeting Multiple DNA, RNA Markers Dec 4, 2013 NYC, Corporate Partners Launch $100M Life Sciences Investment Fund Nov 18, 2013 Qiagen, Lilly Ink Third Companion Test Agreement for Undisclosed Compound Oct 11, 2013 C2N Accelerating Development of Alzheimer's Early Detection Test, Phase III Clinical Trial Markers Premium Sep 19, 2013 Exosome Diagnostics, Eli Lilly Partner on Biomarker Discovery Sep 19, 2013 Lilly to Use Exosome Diagnostics' Nucleic Acid Extraction Kit for Biomarker Research Premium Jul 26, 2013 Proteomic and Metabolomic Study IDs Signature that Could Help Predict Death in Sepsis Patients Premium Jul 10, 2013 Pharma-led Group IDs Recurrent, Druggable Mutations in Liver Cancer Premium Load More Breaking News 23andMe to Acquire Telemedicine Platform Company Lemonaid Health for $400M in Cash, Stock UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.